• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

eisai severance

  1. Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E Endpoints News

    Never. Should. Get. Approved. Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E; Spatial biology outfit grabs $33M round – Endpoints News Biogen, Eisai unveil new data on lecanemab, but questions linger on ARIA-E; Spatial biology outfit grabs $33M round Eisai and...
  2. Severance

    What's the package look like? Just in case the rumors are eventualized.